Toxic Epidermal Necrolysis in a Patient with Allopurinol, Colchicine and Alcohol Use

被引:0
作者
Daye, Munise [1 ]
Temiz, Selami Aykut [2 ]
Arslan, Sevket [3 ]
Yosunkaya, Alper [4 ]
Gumus, Selim [1 ]
Uyanik, Orkun [5 ]
Nursen, Hayri Ahmet Burak [5 ]
机构
[1] Necmettin Erbakan Univ Meram, Tip Fak, Dermatol Ana Bilim Dali, Konya, Turkey
[2] Konya Eregli Devlet Hastanesi, Dermatol Klin, Konya, Turkey
[3] Necmettin Erbakan Univ Meram, Tip Fak, Ic Hastaliklari Ana Bilim Dalt, Immunol & Allerji Hastaliklari Ana Bilim Dali, Konya, Turkey
[4] Necmettin Erbakan Univ Meram, Tip Fak, Anesteziyol & Reanimasyon Ana Bilim Dali, Konya, Turkey
[5] Necmettin Erbakan Univ Meram, Tip Fak, Plast Rekonstruktif & Estetik Cerrahisi Ana Bilim, Konya, Turkey
来源
JOURNAL OF EMERGENCY MEDICINE CASE REPORTS | 2020年 / 11卷 / 03期
关键词
Toxic epidermal necrolysis; allopurinol; colchicine; intravenous immunoglobulin; STEVENS-JOHNSON-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN;
D O I
10.33706/jemcr.684184
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Toxic epidermal necrolysis is a severe, acute, mucocutaneous, life-threatening hypersensitivity syndrome with high mortality and bullous lesions on the skin, eyes and mucous membranes. It often develops due to drugs. Sulfonamide group antibiotics and antiepileptic drugs are the most commonly responsible agents. Allopurinol is a common cause of toxic epidermal necrolysis as in most drug reactions. Colchicine is widely used in dermatology and rheumatology and is generally known as an agent with a broad safety profile. Case report: Here we present a case of toxic epidermal necrolysis in our case with allopurinol, colchicine and alcohol use in order to draw attention to the increased risk of drug coexistence. Conclusion: Again, we wanted to draw attention to the management of our case and the efficacy and safety of high-dose intravenous immunoglobulin therapy.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [41] Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chronopoulos, A.
    Pleyer, U.
    Mockenhaupt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 534 - 539
  • [42] Atypical Nevi in a Patient After Toxic Epidermal Necrolysis
    Balic, Anamaria
    Pavicic, Borna
    Marinovic, Branka
    Toncic, Ruzica Jurakic
    ACTA DERMATOVENEROLOGICA CROATICA, 2018, 26 (02) : 183 - 185
  • [43] Case report of a patient with toxic epidermal necrolysis with complications and review of literature
    Petrovic-Popovic, Dragana
    Petrovic-Elbaz, Mirjana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (3-4) : 208 - 211
  • [44] TOXIC EPIDERMAL NECROLYSIS
    ROHRER, TE
    AHMED, AR
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (07) : 457 - 466
  • [45] Toxic Epidermal Necrolysis Associated with Sorafenib and Tosufloxacin in a Patient with Hepatocellular Carcinoma
    Choi, Mun Ki
    Woo, Hyun Young
    Heo, Jeong
    Cho, Mong
    Kim, Gwang Ha
    Song, Geun Am
    Kim, Moon Bum
    ANNALS OF DERMATOLOGY, 2011, 23 : S404 - S407
  • [46] Penicillamine-induced toxic epidermal necrolysis in a patient with Wilson disease
    Lee, Yoon Im
    Lee, Mu Yeol
    Park, Yong Tae
    Park, Chan Ho
    Sung, Jun Young
    Seo, Ho Seok
    Choi, Seung Won
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2014, 2 (04): : 302 - 305
  • [47] An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Koh, Mark Jean-Aan
    Tay, Yong-Kwang
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (04) : 505 - 510
  • [48] The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Mockenhaupt, Maja
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (06) : 803 - 815
  • [49] Modified Score of Toxic Epidermal Necrolysis to predict toxic epidermal necrolysis mortality
    Dogahe, Zahra Haghani
    Ghorbani, Anahita
    Hallaj, Shahin
    Mobayen, Mohammadreza
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : 254 - 255
  • [50] The use of etanercept for treatment of toxic epidermal necrolysis when toxic shock syndrome is in the differential
    So, Naomi
    Leavitt, Erica
    Aleshin, Maria
    Worswick, Scott
    DERMATOLOGIC THERAPY, 2018, 31 (05)